<DOC>
<DOCNO>
EP-0009154
</DOCNO>
<TEXT>
<DATE>
19800402
</DATE>
<IPC-CLASSIFICATIONS>
A61P-37/00 A61P-31/00 C07C-215/08 C07D-473/30 A61K-31/195 C07D-239/48 A61K-31/519 A61P-37/06 C07D-239/00 A61K-31/13 A61K-31/522 C07C-215/00 <main>C07D-473/30</main> A61P-35/00 C07D-473/00 C07D-473/34 C07D-473/38 C07D-473/40 A61P-37/04 A61P-37/02 A61K-31/185 C07C-233/54 A61P-31/12 C07C-233/00 A61K-31/52 
</IPC-CLASSIFICATIONS>
<TITLE>
complexes of 9-hydroxyalkyl-purines, processes for preparing them and therapeutical compositions containing the complexes as active ingredients.
</TITLE>
<APPLICANT>
newport pharmaceuticalsus<sep>sloan kettering inst cancerus<sep>newport pharmaceuticals international, inc.<sep>sloan-kettering institute for cancer research<sep>newport pharmaceuticals international, inc.1590 monrovia boulevardnewport beach californiaus<sep>sloan-kettering institute for cancer research1275 york avenuenew york, new york 10021us<sep>newport pharmaceuticals international, inc.<sep>sloan-kettering institute for cancer research<sep>
</APPLICANT>
<INVENTOR>
hadden john winthrop<sep>simon lionel norton<sep>hadden, john winthrop<sep>simon, lionel norton<sep>hadden, john winthrop150 east 61st streetnew york new yorkus<sep>simon, lionel norton11772 las palmassanta ana californiaus<sep>hadden, john winthrop<sep>simon, lionel norton<sep>hadden, john winthrop150 east 61st streetnew york new yorkus<sep>simon, lionel norton11772 las palmassanta ana californiaus<sep>
</INVENTOR>
<ABSTRACT>
compounds of the formula    where x is oh, nh₂, sh, or or sr (where r is alkyl of 1 to 4  carbon atoms or benzyl), r¹ is h or alkyl of 1 to 8 carbon  atoms, r² is h or methyl, y is the salt of an amine of the  formula    where r³ and r⁴ are lower alkyl, e. g. , 1 to 4 carbon atoms  and n is an integer of 2 to 4 with p-acetamidobenzoic acid  and where z is a number from 0 to 10 are useful as immuno­ modulators, as antivirai agents and in specific cases have  antitumor activity.  the compounds and compositions where  z is 1 to 10 are novel per se.  when r² is h the presence of  y enhances the immunoregulatory activity and the anti­ viral activity.  if x is the nh₂ there is immunoinhibitory ac­ tivity but no immunostimulatory (immunopotentiatory)  activity.  
</ABSTRACT>
</TEXT>
</DOC>
